| Jun 28 |
Protagonist Therapeutics set to join S&P SmallCap 600
|
| Jun 27 |
Protagonist Therapeutics Set to Join S&P SmallCap 600
|
| Jun 27 |
Is Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
|
| Jun 15 |
We Think Some Shareholders May Hesitate To Increase Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) CEO Compensation
|
| Jun 14 |
Protagonist Reports Updated Long Term Results from Rusfertide Phase 2 REVIVE Study at the EHA2024 Congress Showing Durable Hematocrit Control
|
| Jun 9 |
Has Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
|
| Jun 5 |
The 3 Best Biotech Stocks to Buy in June 2024
|
| May 31 |
Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2024
|
